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Hydrogen peroxide  is one of the  most important  antimicrobial  weapons of 
polymorphonuclear leukocytes (PMN)  1 (1), and is also involved in some of their 
antitumor  effects (2).  Our understanding  of hydrogen peroxide metabolism in 
mononuclear  phagocytes  and  its  possible  contribution  to  their  antimicrobial 
and antitumor  mechanisms is much less advanced. 
There  are  striking  similarities  between  PMN  and  many  preparations  of 
mononuclear phagocytes in their metabolic responses to stimuli such as phago- 
cytosis (3-5) or membrane-active agents (6, 7), including the respiratory burst, 
enhanced hexose monophosphate shunt activity, and superoxide production (3- 
7). In PMN, these responses are closely linked to hydrogen peroxide production 
(8-13). 
It would be logical to  expect,  therefore,  that  mononuclear  phagocytes  also 
could be stimulated to bursts of H202 production, although their H202 metabo- 
lism  might  differ  in  some  respects  from  that  in  PMN.  In  particular,  the 
remarkable  plasticity  of structure  and  function  of mononuclear  phagocytes, 
whereby many  of their  attributes  are  susceptible  to  sustained  "activation," 
might lead one to anticipate inducible changes in their metabolism of H~O2. 
In this  study,  use of a  sensitive  and  specific assay for H20~  permitted  the 
demonstration that mouse peritoneal macrophages could be triggered to release 
H202 into the extracellular medium almost as copiously as PMN. The ability to 
trigger  such  release depended on the  state  of activation  of the  macrophages. 
Potential activating agents differed markedly in their ability to prime macro- 
phages for H202 release. 
Materials  and Methods 
Mice.  Mice  of either  sex,  aged  2-8  mo,  were  obtained  as  follows:  (BALB/c  x  DBA/2)F1 
(CDF,), from Flow Laboratories, Inc., Rockville, Md.; C3H/HeN, from the colony of Dr. Malcolm 
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Public Health Service RO1 AI13251. 
$ Scholar of the Leukemia Society of America.  Present address: Rockefeller University, New 
York 10021. 
' Abbreviations  used in this paper:  BCG, Bacille Calmette-Gu~rin; DMSO, dimethyl sulfoxide; 
FCS,  fetal  calf serum;  HBSS,  Hanks'  balanced  salt  solution;  HPO,  horseradish  peroxidase; 
KRPG,  Krebs-Ringer phosphate buffer with glucose; MEMS, Eagle's minimal essential medium 
with  20%  FCS;  NPAC,  nonphagocytic adherent cells;  PMA,  phorbol myristate  acetate;  PMN, 
polymorphonuclear leukocytes; SEM, standard error of the mean. 
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Mitchell, Yale University; and CDI, from Charles River Breeding Laboratories, Wilmington, 
Mass. No differences  in  results  were noted using  different  strains. 
Activating  Agents.  Bacille  Calmette-Gudrin (BCG), Phipps strain,  TMC  1029,  lot  9,  was from 
the Trudeau Institute,  Saranac Lake, N.  Y., and was stored  at -70°C.  0.1 cc~ containing 
approximately 10  ~  viable  organisms, was injected  intraperitoneally  (i.p.).  Formalin-killed Cory- 
nebacterium parvum  (Coparvax), lot CA-449, was the generous gift  of Dr. Richard Tuttle, 
Burroughs Wellcome Co.,  Research Triangle Park, N.C. 0.1 cc containing 0.7 mg in saline  was 
injected  i.p.  Higher doses were associated  with excessive  numbers of  PMN. Thioglycollate  (Difco 
Laboratories,  Detroit,  Mich.) was given i.p.  as 1  cc  of  a 10% solution  in  saline.  Sodium caseinate, 
practical  grade, from Eastman Kodak Co., Rochester, N.Y., was given i.p.  as 1 cc of a 0% 
solution  in saline.  Heat-inactivated (56°C,  30 min) fetal  calf  serum (FCS; Flow Laboratories)  was 
given i.p.  in 1 cc. 
Cell Preparation.  Peritoneal cells were lavaged from normal or previously injected mice as 
described  (14),  except that  phenol  red  was  omitted  from the  Hanks'  balanced  salt  solution 
(HBSS). After centrifugation at 200g, the cell pellet was resuspended in 2 cc of 0.2% saline for 30 
s to lyse erythrocytes. This was important to eliminate exogenous catalase (12). Isotonicity was 
restored with 2 cc of 1.6% saline, additional HBSS was added, centrifugation repeated, and the 
cells resuspended in cold modified Krebs-Ringer phosphate buffer with glucose (KRPG; 120 mM 
NaC1, 4.8 mM KC1, 0.54 mM CaCls, 1.2 mM MgSO4,  15.6 mM sodium phosphate buffer, pH 7.4, 
and 11  mM dextrose). Cell number was determined by counting in a  hemocytometer. Aliquots 
were taken for the HsO2 release assay to provide a  wide range of cell concentrations. Another 
aliquot was air-dried on a  glass slide and stained (Diff-Quik, Harleco,  Philadelphia, Pa.)  for 
differential counts of 300  cells. The percentage of PMN detected was the same if smears were 
prepared in  a  cytecentrifuge. Neutrophils and eosinophils were recorded together as "PMN." 
Another aliquot, containing about 2  x  10  e cells, was added to 2 cc of Eagle's minimal essential 
medium (GIBCO,  Grand Island, N.Y.) containing 100 U penicillin, 100 ~g streptomycin and 0.2 
cc  FCS  per  ml  (MEMS)  in  a  35-ram  plastic dish  (no.  3001,  Falcon Plastics,  Div.  BioQuest, 
Oxnard, Calif.) and allowed to adhere at 37°C under 5% CO2/95% air for 3-4 h. The dishes were 
then vigorously rinsed in four beakers of normal saline and used to assay the amount of adherent 
cell protein, as described (15).  In some experiments, about 2  x  107 cells were plated in 5 cc of 
MEMS in 60-ram plastic dishes for 3 h, the nonadherent cells decanted and plated again for 1 h, 
and the remaining nonadherent cells washed four times in KRPG and assayed. Adherent cells 
from the first plating were harvested with the aid of 12 mM lidocaine hydrochloride as reported 
(16, 17), washed four times in KRPG, and used for the H~O2 assay or assay of protein content. In 
some experiments, peritoneal cells were plated on 11.5  x  22-ram flying coverslips in Leighton 
tubes in MEMS for 3 h; the slips were rinsed in three beakers of normal saline and added directly 
to cuvettes containing KRPG for H~O~ assay. They were positioned in the cuvette in a  standard 
manner so as not to affect the initial fluorescence. After assay, the slips were rinsed again, along 
with matched slips not exposed to the assay, and the adherent cell protein determined. Finally, 
some cells were plated in 35-mm dishes in MEMS for 3 h, rinsed in four beakers of saline, and 
the medium replaced with KRPG (containing scopoletin and horseradish peroxidase-  see below), 
of which samples were taken at intervals for assay. 
Assay for H202 Release.  As described fully (12), the 460-nm emission from reduced scopoletin, 
when excited by light at  350  nm,  is extinguished when scopoletin is oxidized by  H202  in the 
presence of horseradish peroxidase (HPO).  Under assay conditions, the loss of fluorescence was 
proportional to the concentration of H202,  and was recorded continuously (12).  The assay was 
modified slightly as fellows: buffer, KRPG; total volume per cuvette, 3.0 cc; scopoletin, 10 nmol 
per cuvette; HPO, 0.06 mg (about 30 U) per cuvette. The above reagents and the cells were mixed 
by inversion and left in the fluorometer for 5 rain to reach 37°C. A base line reading was made 
for 2 min, a "triggering agent" added, the contents mixed, and fluorescence recorded for at least 
5  rain.  With  flying  coverslips,  fluorescence was  recorded  intermittently  immediately  after 
mixing, with care to reposition the slip in the standard manner. HsO2 release was determined 
from a standard curve prepared under the above conditions with monoethylperoxide (Polysciences, 
Inc.,  Warrington,  Pa.;  12). At  the  same  cell  concentration,  replicates  agreed  within  a  few 
percent. The greatest source of variability within a given experiment was the use of a wide range 
of  cell  concentrations;  at  the lower  cell  concentrations,  H202 release  per cell  tended  to  be greater 
than at  the  higher  cell  concentrations.  Variability  among different  experiments  might  be  related 
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Stimuli for H202 Release.  PMA (12-O-tetradecanoyl-phorbol-13-acetate; Consolidated Midland 
Corp.,  Brewster,  N.Y.) dissolved in dimethylsulfoxide (DMSO,  Sigma Chemical Co.,  St.  Louis, 
Mo.)  was  added  to  give  a  final  concentration  of  0.1  gg  PMA/ml,  0.04%  DMSO  (vol/vol). 
Concanavalin A  (grade III,  Sigma Chemical) was  added to give 42-420  gg/ml.  Cytochalasin B 
(Aldrich Chemical Co., Inc., Milwaukee,  Wis.) in DMSO was added to give 4.2 gg cytochalasin/ 
ml, 0.17% DMSO. The ionophore A23187 was the kind gift of Dr. Robert Hamill, Lilly Research 
Laboratories,  Indianapolis,  Ind.  and was  added  in  DMSO  to  give  0.33  ~g/ml,  0.03%  DMSO. 
Starch granules prepared as described  (18)  were opsonized by mixing for 30 min at 37°C  with 
0.005 cc of pooled normal human serum per milligram starch, and washing three times in KRPG 
by centrifugation.  1 mg of opsonized starch was  added per cuvette,  a  dose selected to  give no 
detectable quenching or light-scattering. 
Other  Reagents.  Catalase  (Sigma  Chemical)  was  added  to  give  2,000-4,000  Sigma  U/ml. 
Superoxide dismutase (Truett Laboratories, Dallas, Tex.) was added to give 42/~g/ml (125 +  U/ 
ml). Ferricytochrome,c (type VI, Sigma Chemical) was added to give 83-138 nmol/ml. 
Use of Adherence  to Estimate Macrophage  Content of Cell Suspensions.  Protein determina- 
tions  on  known  numbers  (by  hemocytometer  count)  of  thoroughly  washed  preparations  of 
adherent peritoneal cells which had been brought back into suspension with the aid of lidocaine 
(16,  17) gave the following results per 10  e cells: cells from untreated mice, 0.0796  _  0.0029 rag; 
cells from mice given thioglycollate 4-5 days previously, 0.1073  -  0.0076 mg (mean +- SEM from 
four  and  three  experiments,  respectively).  These  values  were  greater  than  those  previously 
reported  (14,  19)  for  whole  peritoneal  cell  suspensions,  perhaps  because  the  earlier  values 
reflected the contribution of lymphocytes. However, the results compare well with those reported 
for  adherent  normal  (0.080  rag)  and  thioglycollate-elicited  peritoneal  cells  (0.130  mg)  after 
overnight cultivation (20).  An accurate factor could not be obtained in this manner for adherent 
peritoneal cells from BCG-treated mice because of the high proportion of adherent lymphocytes 
and the difficulty in removing intact macrophages  (17).  The above values were used to convert 
adherent cell protein values determined in each experiment to estimated numbers of adherent 
cells. Because a known number of peritoneal cells had been plated, the percent of peritoneal cells 
that were adherent could be determined.  With cells from mice given BCG, C. parvum, or FCS, 
the same conversion factor was used as for cells from untreated mice, because the stained cells 
appeared to be nearly the same size; for cells from casein-treated mice, which appeared to be 
intermediate in size between normal cells and thioglycollate-elicited cells,  the factor used was 
the mean of the factors for those cell types.  The percentage of macrophages estimated  in the 
above way was compared to the percentage estimated from stained smears. 
Expression  of Data.  The data are presented in the following ways, as specified in the tables. 
(a) as mean H202 release per 106 peritoneal cells (macrophages, lymphocytes, and PMN} over 5 
rain after the addition of the triggering agent,  including the latency period;  (b)  as  in a,  but 
correcting for PMN. The contribution of PMN was determined from the product of the number of 
cells in the cuvette,  the percentage  of PMN  in the suspension,  and a  standard  value  for the 
activity of PMN (see Results). This product was subtracted from the observed H202 release, and 
the remainder was expressed per 106 cells exclusive of PMN (macrophages and lymphocytes); (c) 
as corrected for PMN,  and expressed per 106 macrophages.  The latter were estimated from the 
number of cells in the cuvette and the percentage of cells scored as  macrophages on  stained 
smears. 
To correct base-line values for spontaneous loss of fluorescence, 5-rain recordings were made 
from 14 cell-free preparations over the course of these studies, and the mean rate plus 2 SD (8.9 ~- 
43 pmol scopoletin/min) was subtracted from the resting values observed with cells. This correc- 
tion was not applied to data obtained after addition of a  triggering agent.  Values for triggered 
cells that would have been reduced to zero by such a correction have been so indicated. 
Results 
Composition  of Peritoneal Cell Suspensions.  Two methods were compared 
to estimate the proportion of peritoneal cells that were macrophages  (Table I). 
Differential counts on stained smears had the disadvantage that there appeared 
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TABLE  I 
Composition of Peritoneal  Cell Suspensions 
Mean percent of peritoneal cells ±  SEM 
Injected i.p.  Macrophages by stained  Macrophages by % ad- 
PMN§ 
smears*  herent cells$ 
Nothing  44.56  ±  6.23  (8)  40.72  ±  3.72  (3)  0.64  ±  0.24  (8) 
BCG  47.16  ±  3.72  (16)  45.03  _+ 4.53  (13)  5.76  ±  1.12  (16) 
Thioglycollate  84.23  ±  2.81  (11)  54.96  ±  5.92 (8)  1.31  _+ 0.45  (11) 
Casein  48.10  ±  6.58  (7)  55.85  ±  8.11  (5)  3.24  ±  0.90  (7) 
FCS  27.11  ±  4.30  (5)  25.24  ±  4.09  (5)  2.53  _  0.81  (5) 
C. parvum  38.24  ±  3.07  (14)  46.28  _+ 9.79  (10)  16.33  ±  3.52  (14) 
* Mononuclear cells with reniform nuclei, and/or intermediate to large size, and/or intermediate 
to low nuclear: cytoplasmic ratio on unspun,  air-dried,  stained glass slides, as percentages of 
300 cells scored. Number of experiments in parentheses. 
$ Adherent cellular protein in washed monolayers, converted to number of adherent cells, and 
divided by number of peritoneal cells initially plated, as described in Materials and Methods. 
§ Neutrophils plus eosinophils in stained smears, as percentage of 300 cells scored. 
phages  to typical lymphocytes. Determination of the  proportion of adherent 
cells by protein measurement had the disadvantage that not all adherent cells 
were  macrophages,  and  not  all  macrophages  adhered.  Nonetheless,  on  the 
average, as shown in Table I, the two methods agreed closely when applied to 
peritoneal cells from untreated mice, or mice given BCG, casein, FCS, or C. 
parvum.  With thioglycollate-treated mice, however, a substantial proportion of 
morphologic macrophages  failed to  adhere  (Table  I,  and  observation  of the 
nonadherent cells).  Differential counts on stained smears were selected as an 
estimate of the macrophage content of peritoneal cell suspensions. 
Because human peripheral blood PMN release copious amounts of H202 after 
appropriate stimulation (12), it was important to take into account the effect of 
the PMN that contaminated the peritoneal cell suspensions. Their representa- 
tion, which is summarized in Table I, ranged from 0.64  _+ 0.24% of peritoneal 
cells  from  untreated  mice,  to  16.33  _+  3.52%  of those  from  mice  given  C. 
parvum  i.p. 4-25 days before. To determine their contribution to H202 release, 
peritoneal cell suspensions intentionally enriched for PMN were prepared. 
H202 Release  by PMN.  Peritoneal  cells  were  harvested from mice  given 
thioglycollate, casein, or BCG 18-24 h previously, and from mice with hemoper- 
itoneum. In seven such experiments, the proportion of PMN in the peritoneal 
cell suspension was 46.57  _+  4.37%.  Peritoneal macrophages were not expected 
to release substantial amounts of H202  when harvested this soon after such 
injections, as shown below. Spontaneous H202 release was 0.096  _+ 0.029 nmol/ 
10  e PMN per 5 rain; PMA-induced H202 release was 9.460  +_ 0.994 nmol/106 per 
5  min.  These  figures were  used  to  estimate the  H202  released  by  PMN  in 
peritoneal cell suspensions containing low numbers of PMN. 
Macrophages as a Source of H202.  As shown in Table H, H202 release was 
readily demonstrated when PMA was added to peritoneal cell suspensions from 
BCG-treated mice. In 6 experiments, the change in fluorescence of scopoletin 
was reduced to 2.19  _  1.41% of control when catalase was added (2,000-4,000 
U/ml), and in 10 experiments, it was reduced to 0.00  -+  0.00% of control when 1652  HYDROGEN  PEROXIDE  RELEASE  FROM  MOUSE  PERITONEAL  MACROPHAGES 
TABLE  II 
PMA-Induced H~O~ Release by Adherent and Nonadherent Peritoneal  Cells from BCG- 
Treated Mice 
nmol H2Oz/106 cells per 5 min* 
Exp.  Cells adherent to  Postadherent sus-  Nonadherent 
Initial suspensions  coverslip§  pensionS[  cells¶ 
19  19.51 _ 2.80  -  -  0.23** 
31  9.13 _+ 0.77  -  3.03  0.04** 
93  5.90 ± 0.60  4.81  1.79 +_ 0.32  0.09 
98  5.12 _  0.16  6.29 _+ 1.26  2.10 ± 0.13  0.00 -+ 0.00 
* Mean  -SEM for  replicates (single value where no  SEM  shown).  Corrected for estimated 
contribution of PMN (see text). 
S Peritoneal cells from C3H/HeN mice (experiments  19, 31) or CDF1 mice (experiments 93, 98) 
given BCG from 10 to 25 days previously. Data expressed per 10  ~ macrophages,  as estimated 
from stained smears (see text). No detectable HsO2 release before adding PMA. 
§ Coverslips  with  adherent  cells washed  and  placed  in  fluorometer  for  assay.  Number  of 
adherent cells estimated from protein measurements on matched coverslips  not exposed to 
PMA. No correction made for nonphagocytic adherent cells (NPAC). 
[I Washed monolayers of adherent cells brought back into suspension with the aid of lidocaine. 
Viability by trypan blue exclusion,  71.36 -  6.37%. Data expressed  per 10  ~ viable cells.  No 
correction made for NPAC. 
¶ Viability by trypan blue exclusion, 98.28 -+ 0.61%. 
** Derived from raw data within 2 SD of the mean for rate of spontaneous loss of fluorescence. 
HPO  was omitted.  Given the specificity of these enzymes, these data indicate 
that the recorded fall in fluorescence of scopoletin was the result of release of 
H20~  (12). 
The observed H20~ release could be accounted for by the activity of adherent 
peritoneal cells when they were studied in situ on well-washed coverslips, or to 
a  lesser  extent,  when  they  were  recovered  from  a  well-washed  monolayer 
(Table II). Almost none of the activity could be attributed to nonadherent cells 
(Table  II).  In  one  experiment,  nonphagocytic  adherent  cells  (NPAC)  were 
isolated and assayed, but released no detectable H202. We concluded, therefore, 
that when the contribution of PMN had been subtracted, H202 released by the 
peritoneal cell suspensions arose from macrophages, and not from lymphocytes. 
Effect of Various Treatments of the Mice.  Fresh peritoneal cell suspensions 
from untreated mice did not release significant amounts of H202 in the standard 
assay (Table III). They were  not devoid of H202-releasing capacity, however, 
for  when  large  numbers  of them  were  cultured  in  plastic dishes  for  4-5  h 
including  1-1.5  h  in  the  presence  of  PMA,  A23187,  concanavalin  A  with 
cytochalasin B,  or opsonized starch granules,  there  was  a  substantial fall in 
scopoletin fluorescence in the  supernate,  which could be abolished by adding 
catalase or  omitting  HPO  (data  not  shown).  When  expressed per  106  cells/5 
min, however, this H202 release was small (about 1 nmol). 
Peritoneal  cells  from  mice  given  BCG  1  min  before  sacrifice  resembled 
untreated  peritoneal cells  in  their  lack  of rapid  PMA-induced H202  release 
(Table III). This indicated that the presence of BCG organisms did not in itself 
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TABLE III 
PMA-Induced H202 Release  by Peritoneal  Cells from Mice Treated With Various Agents 
Injectedi.p.  Time from injection to sacrifice 
Before  PMA:  After PMA: nmol HzOz/10  a cells per 5 rain* 
Number  of 
nmol 
For whole sus-  experi- 
HsO2]liP cells/  For whole cell  For macro- 
pension except  phage~ I  ments 
rain**  suspension  PMN§ 
Nothing  -  0.00  ±  0.00  0.14¶  ±  0.06  0.11¶  ±  0.06  0.29~  ±  0.15  7 
BCG  0  rain  0.00 ±  0.00  0.47¶  ±  0.19  0.44¶  ±  0.19  1.08¶  +- 0.47  1 
1 min  0.00  ±  0.00  0.36¶  ±  0.07  0.36¶  ±  0.07  1.26¶  ±  0.25  1 
40 rain  0.00 ±  0.00  0.37¶  ±  0.11  0.28¶  ±  0.11  2.36¶  ±  0.90  1 
1 day  O.00 ±  0,00  1.80  ±  0.20  0.00  ±  0.00  0.00  ±  0.00  1 
2 days  0.02  ±  0.02  1.15  ±  0.19  0.27  ±  0.15  1.14  ±  0.63  1 
3 days  0.00  ±  O.00  1.31  ±  0.05  0.54  ±  0.21  1.65  ±  0.40  2 
4 days  0.01  ±  O.Ol  0.98  ±  0.11  0.41  ±  0.12  2.30  ±  0.67  1 
5 days  0.00  ±  0.0O  1.72  ±  0.17  1.37  ±  0.18  6.51  ±  0.85  1 
7 days  0.00 ±  O.00  1.78  ±  0.08  1.40  ±  0.11  3.16  ±  0.80  2 
10-73 days  0.02 ±  0.02  3.91  ±  0.65  3.62  ±  0.65  7.90  ±  1.65  10 
101 days  0.00  ±  0.00  0.52  ±  0.12  0.43  ±  0.12  0.81  ±  0.23  1 
Thioglycollate  4-14 days  0.00  ±  0.00  0.35  ±  0.08  0.23  ±  0.05  0,28  ±  0.06  10 
multiple injections**  0.00  ±  0.00  1.15  ±  0.48  0.98  ±  0.37  2.84  ±  0.83  2 
Casein  4-7 days  0.02  ±  0.02  2.04  ±  0.62  1.90  ±  0.63  5.27  ±  1.02  3 
14 days  0.00  0.52  ±  0.06  0.43  ±  0.07  1.17  ±  0.18  1 
multiple injections*$  0.00  ±  0.00  2.31  ±  0.60  1.89  ±  0.61  3.08  ~_ 1.07  4 
C. parvum  4-25 days  0.01  ±  0.01  1.30  ±  0.49  0.93  ±  0.36  2.76  ±  0.95  6 
FCS  1-11 days§§  0.00 ±  0.00  0.34¶  ±  0.06  0.15¶  ±  0.05  0.67¶  ±  0,28  5 
* Means  ±  SEM.  For  single  experiments,  these  values  were  derived  from  the  results  for  different  cell  concentrations.  For  pooled 
experiments,  the values were derived from the means for each experiment. 
Corrected  for the contribution  of PMN and for spontaneous  loss of fluorescence  (see text). 
§ See text. 
[[ Proportion of macrephnges  in cell suspensions estimated from stained  smears  (see text). 
¶  Value based  on low cell numbers  and/or low activity  per  106 cells such that  raw data  were  within  2  SD from the  mean  for rates  of 
spontaneous  loss of fluorescence. 
** Injections were given 13 and 5 days before sacrifice in the first experiment,  and 17 and 9 days in the second. 
~* In two experiments,  double injections were  given,  at  12 and 4 days,  and at  14 and 6  days before  sacrifice.  In two experiments,  triple 
injections were given, at 21,  13, and 5 days,  and at 26, 18, and 4 days before sacrifice. 
§§ Single injections were given 1, 3, 5, or 11 days before sacrifice. In one experiment,  injections were given 7 and 4 days before sacrifice. A 
value  of  more  than  2  SD  greater  than  the  mean  for  rates  of spontaneous  lose  of  fluorescence  was  found  only  in the  experiment 
performed  11 days aRer injection (1.71 nmol/10  s macrephages). 
release with time after injection of BCG, which was first evident at 49 h  and 
continued to mount over about 10 days. Thereafter, PMA-induced H202 release, 
nearly as copious as that seen with mouse peritoneal PMN, was seen for 10 wk 
after BCG injection (Table III). The only exceptions were two experiments (not 
shown) using BCG that had thawed during shipment; here, H202 release was 
only one-fifth that shown for equivalent times after injection of BCG shipped 
frozen. The viability of the thawed shipment of BCG was about one-quarter 
that of the frozen shipment, as determined by colony counts. 
Macrophages from mice given thioglycollate 4-5 days previously were more 
spread out and vacuolated, and had a higher protein content, than those from 
BCG-treated  or  untreated  mice.  Surprisingly,  however,  they released  very 
little detectable H202 in response to PMA. This was so whether the cells were 
studied 4  (six  experiments),  5  (two  experiments),  7  (one  experiment),  or  14 1654  HYDROGEN  PEROXIDE  RELEASE  FROM  MOUSE  PERITONEAL  MACROPHAGES 
days  (one experiment)  after injection of thioglycollate (data pooled in Table 
III). The rate of H202 release did not increase when the cells were observed for 
over an hour after adding PMA (data not shown). 
When  1  ×  10  e peritoneal  cells  from a  BCG-treated  mouse,  releasing 4.36 
nmol H2OJ5 min after PMA, were mixed with 1  ×  108 peritoneal cells from a 
thioglycollate-treated mouse,  themselves  releasing  0.004  nmol,  the  mixture 
released only 1.54 nmol when exposed to the same amount of PMA. This was 
consistent with catabolism of H20~ by thioglycollate-induced peritoneal cells, 
or  with  the  oxidation  by  H202  of  moieties  associated  with  the  cells,  in 
competition with scopoletin. 
When mice were given a  second injection of thioglycollate approximately a 
week after the first, and their peritoneal cells collected after another 5-9 days, 
much  more  substantial  H~O~ release  could be  detected in  response  to  PMA 
(Table III). 
The relative capacities for H202 release by macrophages from BCG-treated, 
thioglycollate-treated, or untreated mice were preserved over a  wide range of 
cell concentrations (Fig. 1). 
Peritoneal cells from mice injected with casein released substantial amounts 
of H20~  in response to PMA  (Table III).  H202  release was detectable earlier 
than with BCG (4 days), but appeared to decline faster (by 14 days) and tended 
to be  of lower magnitude.  Multiple injections of casein did not augment the 
response (Table III). 
Treatment with a formalin-killed preparation ofC. parvum yielded peritoneal 
cells with a  modest degree of PMA-induced H20~ release, which appeared to 
peak on the llth day after injecting 0.7 mg (7.42  _+  1.06 nmol/106  macrophages 
per 5 min on day 11). Prodigious degrees of H20~ release, well over 10 nmol/106 
macrophages per 5 min, were seen in three experiments 5 days after injecting 
0.7,  1.4, or 2.1 mg ofC. parvum, but contamination by PMN was high, and the 
results have been excluded from analysis. 
Macrophages from mice given FCS from 1 to 11  days before sacrifice were 
mostly inactive in PMA-induced H~O2 release (Table III). 
Role  of "Triggering"  Agent.  No  matter how the mice had been  treated, 
their  peritoneal  cells  usually  released  no  detectable  H202  in  vitro  until  a 
triggering agent was added  (Table  III).  Four materials were  found to serve 
well  as  triggering agents:  PMA,  the  ionophore  A23187,  concanavalin A  in 
combination with cytochalasin B, and opsonized phagocytic particles. Responses 
to PMA were of the greatest magnitude and shortest latency, but no attempt 
was made in this study to optimize conditions for the use of the other agents, 
and the results are therefore not presented. 
Dose-response curves for PMA over the range 0.005-0.83  ~g/ml were deter- 
mined for peritoneal cells from mice given C. parvum,  thioglycollate, or  no 
treatment,  and  for peritoneal exudates rich  in  PMN.  All  showed a  plateau 
including the standard dose of 0.1  ~g/ml, indicating that differences in H~O~ 
release  among  various  cell  preparations  could  not  be  attributed  to  either 
suboptimal or suppressive doses of PMA. 
As shown in Table  IV,  the onset of H202  release was apparent  about 40  s 
after PMA was added to each type of cell preparation used in this study, with 
two exceptions. Peritoneal cells from untreated mice began to release a  small 30 
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FIG. i.  PMA-induced H202 release  as a function of  the number of macrophages in the 
cuvette. C3H/HeN mice were untreated, or given thioglycollate  4 days or BCG  14 days 
before  collection  of  peritoneal  cells.  Values corrected  for  the contribution  of  PMN  and the 
estimated proportion of macrophages, based on stained smears (untreated mice, 47.5% 
macrophages and 0% PMN; mice given thioglycollate,  77.5% macrophages and 0.5% PMN; 
mice given BCG, 38.5% macrophages and 3% PMN). All assays performed in the same 
experiment. Lines fitted  by the method of  least  squares. 
amount of H202 after about 14 min  (Table IV), whereas the latency for BCG- 
elicited peritoneal cells, when studied adherent to coverslips, was about 2 min. 
The significance of these differences is unclear. 
Derivation  of H202 from  Superoxide.  In  human  peripheral  blood  PMN, 
H202 appears to arise during the respiratory burst mainly from the dismutation 
of superoxide  anion  (13,  21,  22). 2 This  pathway  was  examined  indirectly  in 
peritoneal  cells from BCG-treated  mice.  Ferricytochrome c,  which is reduced 
by  superoxide  and  therefore  diverts  it  from  the  dismutation  reaction  (23), 
abolished H202 release in response to PMA (Table V).  Superoxide dismutase, 
which catalyzes the dismutation of superoxide to H202, overcame the depressive 
effect of ferricytochrome c.  By itself,  superoxide  dismutase  either  had  little 
effect or enhanced the detectable H202 release  (Table V).  These observations 
suggest that  the  H202 released by macrophages  from BCG-treated  mice was 
derived from superoxide anion. 
2  Root, R. K., and J. Metcalf. 1977. Hydrogen peroxide release from human granulocytes 
during  phagocytosis:  relationship  to  superoxide anion  formation  and  cellular  catabolism of  H202. 
Studies of  normal and cytochalasin  B-treated cells.  J. Clin. Invest. In press. 1656  HYDROGEN  PEROXIDE  RELEASE  FROM  MOUSE  PERITONEAL  MACROPHAGES 
TABLE  IV 
Latency of Response to PMA 
Injected i.p.  Onset of H202 release after addition of 
PMA 
Nothing  None apparent in 10 rain (12)* 
BCG  39  -+  1 (61)$ 
Thioglycollate  43  _+  2 (20) 
Casein  40  -+ 3 (15) 
FCS  34  +- 2 (2)§ 
C. parvum  40  -+ 2 (28) 
PMN-rich preparations 
BC~I  42  _+  4 (7) 
Thioglycollate¶  46  _+  3 (14) 
Casein¶  37  -+  1 (4) 
* In  three  experiments  with  prolonged  observation,  of  which  two 
employed cells  adherent to  coverslips,  H202  release  was  observed 
after 14  -+  1 rain. Number of observations in parentheses. 
$ Mean seconds -+ SEM. With cells adherent to coverslips, latency was 
about 2 rain. 
§ In seven other observations, no onset of H20~ release was discernible. 
I[ Either 1 day after BCG injection, or from a group of mice all members 
of which had peritonitis, whether or not injected. 
¶ 1 day after injection. 
TABLE  V 
Evidence for Origin of H202 from Superoxide 
nmol HsO2/108 macrophages per 5 min* 
Experi-  With SOD + 
ment$  Peritoneal  With superox-  With ferricy-  ferricyto- 
cells alone  ide dismutase§  tochrome cll  chrome c¶ 
17  8.44  14.41  0  9.61 
23  5.09  4.56  0  4.39 
31B  8.26  9.49  0  5.28 
* PMA-induced H~O2 release corrected for contribution of PMN,  and for the 
proportion of macrophages in the peritoneal cell suspensions, as estimated 
from stained smears. 
* C3H/HeN mice injected with BCG 10, 12, and 22 days before cell collection. 
§ Superoxide dismutase (SOD), final minimum activity per milliliter: 125 U 
in experiments 17 and 23; 250 U in experiment 3lB. 
I[ Ferricytochrome c, final amount per milliliter: 83  nmol in experiments 17 
and 31B;  138 nmol in experiment 23. 
¶ Same amounts as in § and H, except 250 U  SOD in experiment 23. 
Discussion 
Mouse peritoneal macrophages were capable of releasing up to about 8 nmol 
of H202/106 cells per 5 min, a  capacity essentially the same as that of mouse 
peritoneal PMN  (9  nmol) and similar to that reported for human peripheral 
blood PMN (5 nmol) when assayed by the same fluorometric technique.  3 
3 R.  K.  Root and J.  Metcalf.  1977. The  role of extracellular Ca  ++  in  oxidase activation of 
human granulocytes. PMA-induced H202  release greater than 5  nmol/10  e cells per 5  min was 
attainable with human PMN under somewhat different assay conditions, including continuous 
agitation and the presence of azide. Manuscript in preparation. CARL F.  NATHAN AND  RICHARD K.  ROOT  1657 
The data reported here should be regarded as lower limits for rates of H202 
production.  The  assay measured only H202 that  was released from cells and 
that  was  not  expended  in  the  oxidation  of reactants  other  than  scopoletin, 
including  the  cells  or  materials  associated  with  them.  Differences  in  the 
amount of H202 detected by this  assay using different cell preparations  could 
have  been due to differences in the  formation,  catabolism,  or distribution  of 
H202,  or combinations of these.  Studies of oxygen consumption,  specific meta- 
bolic pathways,  and further  cell mixing experiments  may help to distinguish 
among these possibilities. 
If the contribution  of small numbers  of PMN were taken  into account,  the 
remaining H202 release from suspensions of peritoneal cells from BCG-treated 
mice appeared to arise from macrophages.  Nonadherent  peritoneal cells were 
inactive.  When  adherent  peritoneal  cells  were  studied  on  coverslips,  their 
PMA-induced H202 release could account for all the H202 release seen with the 
initial  cell  suspension.  However,  the  5-rain  assay  period  included  a  2-rain 
latency for adherent cells, but only a 39-s latency for the parent cell suspensions. 
Thus,  after  the  latency,  the  rate  of  H202  release  from  adherent  cells  on 
coverslips  was  about  1.5  times  that  of cells  in  suspension.  This  raises  the 
possibility that  adherence  itself may augment the effect of PMA in inducing 
H202  release.  When  adherent  peritoneal  cells  from  BCG-treated  mice  were 
brought  back  into  suspension  with  lidocaine  and jets  of saline,  their  PMA- 
induced  H202 release  was  still  considerable,  but  was  somewhat  less  than 
predicted  from  the  activity  of the  initial  cell  suspension.  Two  factors  may 
account for this  discrepancy.  First,  BCG-elicited peritoneal  cells  appeared to 
adhere  to  plastic  more  tightly  than  those  from  untreated  mice  (17).  Conse- 
quently,  attempts to dislodge them may have inflicted more cell damage than 
previously  described  for  cells  from  untreated  mice  (17).  Second,  the  tight 
adherence of BCG-elicited macrophages  may have resulted  in  enrichment  of 
the  recovered population  for  NPAC,  which  appeared  to  be  inactive  in  H202 
release. Although the proportion of NPAC in the lidocaine-treated suspensions 
was  not  measured  in  the  present  study,  it  was  noted  that  only  37%  of the 
recovered cells  appeared  to be large  macrophages;  the remainder  could have 
been either macrophages or NPAC by morphologic criteria. 
Elicitation  of the  burst  of H202 release  required  two  sequential  stimuli. 
First, the macrophages had to be "activated" by appropriate treatment of their 
donors,  a  process requiring  4 or more days with  the  regimens  used.  Second, 
these primed macrophages had to be "triggered" by any of a  variety of stimuli 
thought to act at the cell membrane. Triggering agents included PMA, a fatty 
acid ester of a  polyfunctional diterpene alcohol; A23187,  an ionophorous anti- 
biotic from fermentation of Streptomyces; concanavalin A, a  phytoglycoprotein 
thought  to  interact  with  macrophage  surface  receptors  (24);  and  opsonized 
particles,  which were phagocytized.  Omission  of either  the  activating  or the 
triggering  stimulus  made  H202  release  almost  undetectable.  This  two-stage 
process  for  inducing  H202  release  is  very  similar  to  the  requirement  for 
sequential  "priming"  and  triggering  in  induction  of plasminogen  activator 
release from mouse peritoneal macrophages  (25). 
Not all agents commonly used to activate macrophages sufficed to activate 
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gave the most profound,  prolonged,  and  consistent activation  in this  regard. 
Low doses of a  nonviable  preparation  of C. parvum  gave activation of much 
briefer duration.  Peritoneal macrophages were also effective over a  relatively 
brief period  after  injection  of casein.  Macrophages  from  mice  treated  with 
BCG,  C.  parvum,  or  casein  were  less  spread  out  and  less  vacuolated  than 
macrophages  from thiogiycollate-treated mice.  The latter have been reported 
to  be  highly  activated  not  only  morphologically  but  also  with  regard  to 
pinocytosis (20),  complement receptor-mediated plmgocytosis (26),  ATP levels 
(27), and secretion of collagenase (28), elastase (29), and plasminogen activator 
(30).  Yet  thioglycollate-elicited  macrophages were  only  slightly  more  active 
than  macrophages  from  untreated  or  FCS-injected  mice  in  detectable  H202 
release. 
It  has  become  increasingly  evident  that  many  features  of  macrophage 
activation  can  be dissociated from  each  other  (14,  18,  31,  32).  Activation  is 
therefore  not  a  stereotypic  response,  and  different  regimens  for  inducing 
activation  cannot  be  regarded  as  equivalent.  Antitumor  activity  has  been 
ascribed to  macrophages  from mice treated  with  BCG  (e.g.  33)  and  with C. 
parvum  (e.g. 34), but has repeatedly been absent with macrophages from mice 
treated  with thioglycollate  (31,  32).  The  antitumor  activity of casein-elicited 
and FCS-elicited mouse peritoneal macrophages has not to our knowledge been 
tested. Thus, in a rough way, based on the evidence available so far, activation 
for H20~ release and activation for antitumor  activity may be correlated. 
Recent studies with human PMN have shown that their PMA-induced H202 
release accounts for at least 70% of their oxygen consumption during the PMA- 
induced  respiratory  burst  (see  footnote  3).  If PMA-induced  H202  release  by 
macrophages from BCG-treated mice also proves to account for a  substantial 
fraction  of their  increment  in  oxygen consumption,  this  would suggest  that 
formation  of H202  is  of  considerable  importance  in  the  physiology  of the 
macrophage,  and  would  give weight  to  the  hypothesis  that  H202 formation 
may  play  an  important  role  in  the  enhanced  antimicrobial  and  antitumor 
capacities ascribed to macrophages activated in certain ways. 
Previous measurements of H202 formation or release have been reported for 
mononuclear  phagocytes  from  several  species  and  anatomic  compartments, 
using  various methods  of elicitation  of the  cells  and  a  number  of assays for 
H202.  Data  from most of these studies have been included  in Table VI.  The 
limitations  of several  of the  indirect  methods  for  assaying  H20~  have  been 
discussed by Klebanoff (35).  The importance of taking into account the degree 
of contamination  by PMN  deserves  emphasis.  With  macrophages  active  in 
H202 release,  such as those from BCG-treated mice, the relative contribution 
by PMN to total  H202 release  (mean,  7.42%)  tended to be about the same as 
their relative number in the cellular preparation  (mean,  5.76%).  With poorly 
active macrophages, however, a  substantial proportion of total H202 release by 
peritoneal cells could be attributed to small numbers of contaminating  PMN. 
Judging from Table VI,  the  main  differences between the present  study and 
previous studies appeared to be (a)  an assay that is probably more sensitive; 
(b) a triggering agent that may result in greater extracellular release (although 
this point has not been thoroughly explored); and  (c) the recognition that the 
peritoneal cells must be activated or elicited in an appropriate way. Compartment, 
species 
Peritoneal, 
mouse 
Peritoneal, 
guinea pig 
Alveolar,  rabbit 
Blood, human 
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TAnLE VI 
Reports of H202 Production or Release by Mononuclear Phagocytes 
' Activity  of stim- 
Activity (resting ~  Stimulus  ulated cells, 
stimulated)  nanomole/10  e 
eells per 5 rain* 
0.02 --, 7.90 nm/  PMA 
10e/5 rain 
0.02 -, 5.27 nm/  PMA 
10e/5 rain 
9.00 ~  0.29§ nm/  PMA 
10~/5 rain 
108.2 ~  177.5 nm/  phag** 
10"/30 rain 
1.2 --, 1.25 nm/10°/h  phag 
ND --, ND +  3.7 nm/i  phag 
mg pret/h 
ND ~  ND +  17.1  phag 
nm/mg prot/h 
16.9 --* 129.5 pmol/  phag 
5 ×  10elh 
6.3 ---,  40.1 nm/10~/h  phag 
Eliciting agent  PMN  Assay 
% 
BCG  5.76  Scop fluor~ 
Casein  3.24  Scop fluor 
None  0.64  Scep fluor 
Glycogen (24 h)  NI~J  LDADCFI 
None  ND  formate  oxida- 
tion 
Casein  ND  formate  oxida- 
tion 
Casein  ND  formate  oxida. 
tion 
None  1.4  Scop fluor 
BCG +  oil  ND  formate  oxida- 
tion  w.  cata- 
lase 
None  ND  LDADCF 
None  <2  LDADCF 
None  1.0  Scep fluor 
None  5  formate  oxida- ! 
tion w.  cata- 
lase 
59.2 ~  69.0 nm/  phag 
10s/30 rain 
0.163 ~  0.306 nm/  phag 
10e/120 rain 
0.2 --, 0.8 nm/106/  phag 
5 min 
--0 ~  0.44 nm/107/b  phag 
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Patients  (nee-  0  formate  oxida-  0.68 ~  3.6 nm/ 
tropenic)  tion  107/30 rain 
* Values from the present report are corrected  for contribution of H2Oz by PMN. 
Scopoletin fluorescence. 
Refer- 
First author 
ence 
phag 
7.90  Nathan 
5.27  Nathan 
0.29§  Nathan 
0.30  Paul  36 
0.10  Karnovsky  37 
ND + 0.0255  Karnovsky  37 
ND +  0.1155  Karnovsky  37 
0.002  Bolen  38 
0.33  Klebanoff  35 
O. 12  Paul  36 
0.01  Gee  39 
0.8  Adler  §§ 
0.004  Sagone  40 
0.06  Baehner  41 
§ Value derived from raw data not significantly  different from rate of spontaneous loss of fluorescence, 
[I Data not determined. 
¶ Leucodiacetyl-2,7-dichlorofluorescein  fluorescence. 
** Phagocytosis. 
~$ Estimated by converting milligram  cell protein to number of cells as described in Materials and Methods. 
§§ L. Adler and R. K. Root.  Manuscript in preparation. 
With  a  latency  of about  40  s  afLer  addition  of  a  triggering  agent,  H2O  2 
release  appears to be one of the fastest macrophage responses to any stimulus 
that  has  been  susceptible  to  quantitation.  As  such,  it  may  be  suited  to  the 
analysis  of the interaction  of various agents  with  the cell  membrane  and its 
receptors.  It is  also of interest  that the ratio of H202  release  obtainable  with 
BCG-activated  macrophages compared to untreated macrophages is one of the 
largest quantitative changes reported to be associated with macrophage activa- 
tion.  The  fluorometric  assay  for  H2O  2 release  is sensitive to the  H202  output 
from  as  few  as  2  ×  105  macrophages,  when  appropriately  activated  and 
triggered,  and  thus  permits  studies  to  be  made  upon  cells  from  individual 
mice. It is hoped that this assay will facilitate the experimental approach to a 
variety of questions concerning the interaction of macrophages with lymphocyte 
mediators,  cell  surface  ligands,  microbes,  other  particulates,  and  nucleated 
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Summary 
Using a  specific and sensitive fluorometric assay, the H202 release from as 
few as 2  x  105 mouse peritoneal macrophages could be detected continuously 
and quantitated.  It is emphasized that the assay measured H202 release, not 
production.  Induction of HsO2 release required sequential application of two 
stimuli: the administration of an activating agent to the mice from 4 days to 10 
wk before cell harvest,  and the exposure of the cells in vitro to a  triggering 
agent.  BCG was most effective as an activating agent, resulting in peritoneal 
macrophages which could be triggered to release H202 almost as copiously (8 
nmol/108 macrophages per 5 min) as mouse peritoneal PMN  (9 nmol/106 PMN 
per 5 min). Casein and C. parvum could also serve as activators, but thioglycol- 
late  and  FCS  were  ineffective  after  single  injections.  PMA  was  a  potent 
triggering agent, resulting in a  maximal rate of H20~ release after a latency of 
about  40  s  for  cells  in  suspension.  Other  triggering  agents  included  the 
ionophore  A23187,  concanavalin  A  in  the  presence  of cytochalasin  B,  and 
phagocytosis.  H202 release could be  attributed to macrophages and  PMN  in 
peritoneal cell suspensions or in preparations of adherent peritoneal cells, but 
not to lymphocytes. Indirect evidence suggested that  the  HsOs  detected was 
formed from superoxide anion.  These observations appear to justify renewed 
interest in the idea that H202 may be important in macrophage antimicrobial 
and antitumor mechanisms. 
We thank Ms. Julie  Metcalf for advice,  Dr.  Richard L.  Tuttle for C. parvum,  and Dr.  Robert 
Hamill for A23187. 
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